Professional Dietetics and Bixink Therapeutics, a subsidiary of KPS Corporation in Korea, have entered in to a partnership for the MUCOSAMIN® range whereby Bixink will hold the exclusive distribution rights in the Asian region.
MUCOSAMIN is an innovative Medical Device composed of Hyaluronic Acid and a patented cluster of Amino Acids to prevent and treat mucositis induced by radio/chemo therapy.
Starting from Korea and Japan, the partnership will move soon to other countries where BIXINK acquired the first right of refusal:
• Hong Kong
The partnership, thanks to the synergy between MUCOSAMIN and Bixink’s oncology portfolio, aims to reach a mutual growth in the area focusing on innovation in oncology and supportive care.